Sanuwave Health Inc (SNWV)

R&D Expense Growth

-4.85%

Quarterly · Period ending:

SNWV logo

SNWV R&D Expense Growth

Latest reported-4.85%
SNWV Quarterly R&D Growth (QoQ) (0.00% → -4.85%)
High-resolution chart · PNG

SNWV r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Sanuwave Health Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-4.8485%
8.9109%
75.6522%
77.8351%
-6.7308%
35.0649%
-4.3478%
-17.4359%
19.6319%
13.986%
-13.3333%
18.705%
6.1069%
79.4521%
-53.5032%
-8.1871%
3.012%
-6.7416%
-40.0673%
9.1912%
-23.1638%
35.274%
-39.4234%
63.0189%
-7.6655%
-8.6182%
4.7229%
-2.3985%
17.7282%
-8.2016%
-57.0341%
79.655%
5.4066%
6.7177%
22.7142%
-39.0657%
68.2079%
242.3473%
-71.4624%
-44.0379%
53.6246%
-39.4942%
-9.9908%
24.5945%
-28.022%
23.4661%
-27.4314%
-30.1236%
32.5304%
38.6274%
-28.8752%
24.2075%
81.1895%
-6.9827%
-15.8187%
26.6218%
-42.4237%
7.1847%
-9.6249%
-21.6069%
6.1149%
-16.4899%
-10.2982%
11.6802%
-17.5256%
54.9081%
-34.1047%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.